JF

Jeffrey Finer

Venture Partner at Third Rock Ventures

South San Francisco, California

Overview

Work Experience

S

Septerna

  • CEO and Co-Founder

    2019 - Current

TR

Third Rock Ventures

  • Venture Partner

    2016

MT

Maze Therapeutics

  • Board Observer

    2019

  • Interim Chief Technology Officer

    2016 - 2019

S

Strateos

  • Board Member

    2019 - 2024

  • Board Chairman

    2019 - 2022

AM

Ambys Medicines

  • Board Observer

    2019 - 2022

  • Interim Chief Technology Officer

    2017 - 2019

Transcriptic

  • Board Member

    2018 - 2019

TB

Theravance Biopharma, Inc.

  • Vice President, Research Technology

    2014 - 2016

  • Vice President, Molecular & Cellular Biology

    2011 - 2014

Five Prime Therapeutics

  • Vice President, Discovery

    2007 - 2011

C

Cytokinetics

  • Director, Drug Discovery Technologies

    1998 - 2007

ME

Massachusetts Eye and Ear

  • Resident Physician & Surgeon, Ophthalmology

    1996 - 1998

Education

Investments

Septerna

Series A

Total Funding: $250M

Relevant Websites